Evidence map›Paper›PMID 40703816›Full record

ArticleResuscitation plus2025

Neurofilament, but not Alzheimer disease biomarkers in the acute phase correlate with cognitive performance after cardiac arrest.

Johannes Lorentzson, Gisela Lilja, Erik Blennow Nordström, Kaj Blennow, Henrik Zetterberg, Christian Hassager, Matt P Wise, Andrea L Benedet, Tommaso Pellis, Hans Friberg and 2 more

Abstract read
In one paragraph

Article in Resuscitation plus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Johannes LorentzsonDepartment of Neurology, Skane University Hospital, Lund, Sweden.
Gisela LiljaDepartment of Neurology, Skane University Hospital, Lund, Sweden.
Erik Blennow NordströmDepartment of Clinical Sciences Lund, Lund University, Lund, Sweden.
Kaj BlennowClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Henrik ZetterbergClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Christian HassagerDepartment of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Matt P WiseAdult Critical Care, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.
Andrea L BenedetDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Tommaso PellisDepartment of Anaesthesiology and Intensive Care, Pordenone Hospital, Azienda Sanitaria Friuli Occidentale, Italy.
Hans FribergDepartment of Clinical Sciences Lund, Lund University, Lund, Sweden.
Nicholas AshtonClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Marion Moseby KnappeDepartment of Neurology, Skane University Hospital, Lund, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Biomarkers serve as a quantitative measure of brain injury and may predict cognitive outcome after cardiac arrest. This study investigates the association and predictive accuracy of acute changes in Alzheimer disease-associated biomarkers to cognitive outcome in cardiac arrest survivors. Methods: Retrospective study of the Target Temperature Management after Out-of-Hospital cardiac arrest trial. Serum from adult cardiac arrest survivors was sampled prospectively at 24, 48, and 72 h post-arrest and analyzed for peak-levels of Alzheimer disease markers (p-tau Results: 206/342 (60 %) survivors from participating sites were included. Median was age 62 (IQR 53-69), 86 % male, 15 (7 %) had Mini-Mental State Examination (MMSE) scores < 24. Alzheimer disease biomarkers exhibited at best small correlations to cognitive outcomes (rho = -0.22 to 0.18). The correlation between outcome instruments and NfL was rho = -0.32 to -0.20 ( Conclusion: In contrast to tau- and amyloid-related biomarkers, NfL could be more useful for predicting cognitive function in cardiac arrest survivors. Low participation by survivors with severe brain injury may have influenced results.

Indexed as

Amyloid betaCognitive impairmentNeurofilament lightNeuroprognosticationOHCATau

Identifiers

PMID40703816
PMCPMC12284371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.